Towards a standardized human proteome database: Quantitative proteome profiling of living cells

Comparative proteome profiling, performed by two‐dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein express...

Full description

Saved in:
Bibliographic Details
Published inProteomics (Weinheim) Vol. 4; no. 5; pp. 1314 - 1323
Main Authors Traxler, Elisabeth, Bayer, Editha, Stöckl, Johannes, Mohr, Thomas, Lenz, Christof, Gerner, Christopher
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 01.05.2004
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Comparative proteome profiling, performed by two‐dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein expression database of human cells, facilitating data comparisons between different laboratories, exists. Recently, we have published two‐dimensional polyacrylamide gel electrophoresis‐based techniques to assess absolute protein data comprising protein amounts, synthesis rates and biological half‐lives (Mol. Cell. Proteomics 2002, 1, 528–537). Determination of protein amounts by fluorography of two‐dimensional gels was followed by the exact quantification of the amount of incorporated 35S radiolabel. Here we demonstrate an application of this highly standardized method to quiescent human T cells, phythaemagglutinin‐stimulated T cells and Jurkat cells, a human T lymphoblast cell line. While the protein composition of quiescent T cells differed significantly compared to that of Jurkat cells, it was only slightly different compared to the activated T cells. Synthesis profile analyses demonstrated that activated T cells clearly differed from the quiescent cells, performing apparently almost like lymphoblast cells. The great sensitivity of this approach was further demonstrated with human umbilical vein endothelial cells treated for six hours with vascular endothelial growth factor. While no significant alteration of protein amounts was detected at all upon activation, the synthesis rate of several proteins was found to be more than doubled.
AbstractList Comparative proteome profiling, performed by two‐dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein expression database of human cells, facilitating data comparisons between different laboratories, exists. Recently, we have published two‐dimensional polyacrylamide gel electrophoresis‐based techniques to assess absolute protein data comprising protein amounts, synthesis rates and biological half‐lives (Mol. Cell. Proteomics 2002, 1, 528–537). Determination of protein amounts by fluorography of two‐dimensional gels was followed by the exact quantification of the amount of incorporated 35S radiolabel. Here we demonstrate an application of this highly standardized method to quiescent human T cells, phythaemagglutinin‐stimulated T cells and Jurkat cells, a human T lymphoblast cell line. While the protein composition of quiescent T cells differed significantly compared to that of Jurkat cells, it was only slightly different compared to the activated T cells. Synthesis profile analyses demonstrated that activated T cells clearly differed from the quiescent cells, performing apparently almost like lymphoblast cells. The great sensitivity of this approach was further demonstrated with human umbilical vein endothelial cells treated for six hours with vascular endothelial growth factor. While no significant alteration of protein amounts was detected at all upon activation, the synthesis rate of several proteins was found to be more than doubled.
Comparative proteome profiling, performed by two-dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein expression database of human cells, facilitating data comparisons between different laboratories, exists. Recently, we have published two-dimensional polyacrylamide gel electrophoresis-based techniques to assess absolute protein data comprising protein amounts, synthesis rates and biological half-lives (Mol. Cell. Proteomics 2002, 1, 528-537). Determination of protein amounts by fluorography of two-dimensional gels was followed by the exact quantification of the amount of incorporated super(35)S radiolabel. Here we demonstrate an application of this highly standardized method to quiescent human T cells, phythaemagglutinin-stimulated T cells and Jurkat cells, a human T lymphoblast cell line. While the protein composition of quiescent T cells differed significantly compared to that of Jurkat cells, it was only slightly different compared to the activated T cells. Synthesis profile analyses demonstrated that activated T cells clearly differed from the quiescent cells, performing apparently almost like lymphoblast cells. The great sensitivity of this approach was further demonstrated with human umbilical vein endothelial cells treated for six hours with vascular endothelial growth factor. While no significant alteration of protein amounts was detected at all upon activation, the synthesis rate of several proteins was found to be more than doubled.
Comparative proteome profiling, performed by two-dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein expression database of human cells, facilitating data comparisons between different laboratories, exists. Recently, we have published two-dimensional polyacrylamide gel electrophoresis-based techniques to assess absolute protein data comprising protein amounts, synthesis rates and biological half-lives (Mol. Cell. Proteomics 2002, 1, 528-537). Determination of protein amounts by fluorography of two-dimensional gels was followed by the exact quantification of the amount of incorporated (35)S radiolabel. Here we demonstrate an application of this highly standardized method to quiescent human T cells, phythaemagglutinin-stimulated T cells and Jurkat cells, a human T lymphoblast cell line. While the protein composition of quiescent T cells differed significantly compared to that of Jurkat cells, it was only slightly different compared to the activated T cells. Synthesis profile analyses demonstrated that activated T cells clearly differed from the quiescent cells, performing apparently almost like lymphoblast cells. The great sensitivity of this approach was further demonstrated with human umbilical vein endothelial cells treated for six hours with vascular endothelial growth factor. While no significant alteration of protein amounts was detected at all upon activation, the synthesis rate of several proteins was found to be more than doubled.
Comparative proteome profiling, performed by two‐dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually relies on the relative comparison of samples of interest with respect to a reference. Currently, no standardized quantitative protein expression database of human cells, facilitating data comparisons between different laboratories, exists. Recently, we have published two‐dimensional polyacrylamide gel electrophoresis‐based techniques to assess absolute protein data comprising protein amounts, synthesis rates and biological half‐lives ( Mol. Cell. Proteomics 2002, 1 , 528–537). Determination of protein amounts by fluorography of two‐dimensional gels was followed by the exact quantification of the amount of incorporated 35 S radiolabel. Here we demonstrate an application of this highly standardized method to quiescent human T cells, phythaemagglutinin‐stimulated T cells and Jurkat cells, a human T lymphoblast cell line. While the protein composition of quiescent T cells differed significantly compared to that of Jurkat cells, it was only slightly different compared to the activated T cells. Synthesis profile analyses demonstrated that activated T cells clearly differed from the quiescent cells, performing apparently almost like lymphoblast cells. The great sensitivity of this approach was further demonstrated with human umbilical vein endothelial cells treated for six hours with vascular endothelial growth factor. While no significant alteration of protein amounts was detected at all upon activation, the synthesis rate of several proteins was found to be more than doubled.
Author Lenz, Christof
Traxler, Elisabeth
Bayer, Editha
Gerner, Christopher
Mohr, Thomas
Stöckl, Johannes
Author_xml – sequence: 1
  givenname: Elisabeth
  surname: Traxler
  fullname: Traxler, Elisabeth
  organization: Institute of Cancer Research
– sequence: 2
  givenname: Editha
  surname: Bayer
  fullname: Bayer, Editha
  organization: Institute of Cancer Research
– sequence: 3
  givenname: Johannes
  surname: Stöckl
  fullname: Stöckl, Johannes
  organization: Institute of Immunology, University of Vienna, Vienna, Austria
– sequence: 4
  givenname: Thomas
  surname: Mohr
  fullname: Mohr, Thomas
  organization: Institute of Cancer Research
– sequence: 5
  givenname: Christof
  surname: Lenz
  fullname: Lenz, Christof
  organization: Mass Spectrometry Laboratories, Applied Biosystems, Darmstadt, Germany
– sequence: 6
  givenname: Christopher
  surname: Gerner
  fullname: Gerner, Christopher
  email: christopher.gerner@meduniwien.ac.at
  organization: Institute of Cancer Research
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15188398$$D View this record in MEDLINE/PubMed
BookMark eNqFkM1P3DAQxa2Kiu9rj1VO3LL1xHZsc0Mr2FJRWhCIozWJZ4shH0ucQOlfT1a7WnrjNE-a33uaeXtsq2kbYuwL8Alwnn1b1KGcZJwLzrWWn9gu5KBSa3LY2mgldthejA-cgzZWb7MdUGCMsGaXuZv2BTsfE0xij40fdfhHPrkfamySRdf21NaUeOyxwEjHydWATR967MMzve9HMQ9VaP4k7TypwvNSlVRV8YB9nmMV6XA999nt2enN9Ht68Wt2Pj25SEsFuUyNlb5EAm9UpgorwRBKNNxKO77pQZakyBdSFoJLgNxmJXkBoFVuUFgU--xolTte8jRQ7F0d4vICbKgdotMZBy5k9iEI2mqZSTOCkxVYdm2MHc3dogs1dq8OuFt275bdu033o-HrOnkoavLv-LrsEbAr4CVU9PpBnPv983z6f3i68obY09-NF7tHl2uhlbu7nLn8Ul9nsx9nTog3wEah8g
CitedBy_id crossref_primary_10_1371_journal_pone_0035915
crossref_primary_10_1002_cfg_357
crossref_primary_10_1002_pmic_200500135
crossref_primary_10_1371_journal_pone_0114158
crossref_primary_10_1002_elps_201300581
crossref_primary_10_1021_pr801085g
crossref_primary_10_1002_pmic_200600097
crossref_primary_10_1002_prca_200800173
crossref_primary_10_1002_elps_200900072
crossref_primary_10_1021_pr800438f
crossref_primary_10_1002_pmic_200600323
crossref_primary_10_1007_s00420_010_0513_7
crossref_primary_10_1002_pmic_201000507
crossref_primary_10_1016_j_jprot_2012_07_012
crossref_primary_10_1002_prca_200780100
Cites_doi 10.1002/(SICI)1097-4644(19990315)72:4<470::AID-JCB3>3.0.CO;2-V
10.1172/JCI107470
10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.0.CO;2-C
10.1016/S1359-6446(02)02396-6
10.1074/mcp.M200074-MCP200
10.1016/0003-2697(88)90209-6
10.1002/rcm.379
10.1074/mcp.E300003-MCP200
10.1016/S1044-0305(01)00316-6
10.1074/jbc.M006495200
10.1021/ac9810516
10.1074/mcp.M200026-MCP200
10.1038/sj.cdd.4401010
10.1038/35057062
10.1038/85686
ContentType Journal Article
Copyright Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: Copyright © 2004 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
7X8
DOI 10.1002/pmic.200300774
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
Engineering Research Database
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Anatomy & Physiology
Chemistry
EISSN 1615-9861
EndPage 1323
ExternalDocumentID 10_1002_pmic_200300774
15188398
PMIC200300774
ark_67375_WNG_6N7R2GJF_3
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OC
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5VS
66C
702
7PT
8-1
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACIWK
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SUPJJ
SV3
UB1
V2E
W8V
W99
WBKPD
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XPP
XV2
Y6R
ZGI
ZZTAW
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
ACRPL
ACYXJ
CITATION
7QO
8FD
FR3
P64
7X8
ID FETCH-LOGICAL-c5164-894dcae1d8525b9418ea4a80949100d14ce5edb44b30411692ced3117568a39a3
IEDL.DBID DR2
ISSN 1615-9853
IngestDate Wed Dec 04 06:09:26 EST 2024
Wed Dec 04 09:14:12 EST 2024
Fri Dec 06 03:15:40 EST 2024
Sat Sep 28 07:42:23 EDT 2024
Sat Aug 24 00:53:31 EDT 2024
Wed Oct 30 09:56:22 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5164-894dcae1d8525b9418ea4a80949100d14ce5edb44b30411692ced3117568a39a3
Notes istex:D057C09A810C4003E8D01E3708226DA8994DD2BC
ark:/67375/WNG-6N7R2GJF-3
ArticleID:PMIC200300774
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.200300774
PMID 15188398
PQID 17974248
PQPubID 23462
PageCount 10
ParticipantIDs proquest_miscellaneous_72010342
proquest_miscellaneous_17974248
crossref_primary_10_1002_pmic_200300774
pubmed_primary_15188398
wiley_primary_10_1002_pmic_200300774_PMIC200300774
istex_primary_ark_67375_WNG_6N7R2GJF_3
PublicationCentury 2000
PublicationDate May 2004
PublicationDateYYYYMMDD 2004-05-01
PublicationDate_xml – month: 05
  year: 2004
  text: May 2004
PublicationDecade 2000
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle Proteomics (Weinheim)
PublicationTitleAlternate Proteomics
PublicationYear 2004
Publisher WILEY-VCH Verlag
WILEY‐VCH Verlag
Publisher_xml – name: WILEY-VCH Verlag
– name: WILEY‐VCH Verlag
References Hanash, S., Drug Discov. Today 2002, 7, 797-801.
Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C. et al., Nature 2001, 409, 860-921.
Kislinger, T., Rahman, K., Radulovic, D., Cox, B. et al., Mol. Cell. Proteomics 2003, 2, 96-106.
Washburn, M. P., Wolters, D., Yates, J. R., 3rd, Nat. Biotechnol. 2001, 19, 242-247.
Gerner, C., Vejda, S., Gelbmann, D., Bayer, E. et al., Mol. Cell. Proteomics 2002, 1, 528-537.
Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R., J. Clin. Invest. 1973, 52, 2745-2756.
Rabilloud, T., Strub, J. M., Luche, S., van Dorsselaer, A., Lunardi, J., Proteomics 2001, 1, 699-704.
Gerner, C., Frohwein, U., Gotzmann, J., Bayer, E. et al., J. Biol. Chem. 2000, 275, 39018-39026.
Clauser, K. R., Baker, P., Burlingame, A. L., Anal. Chem. 1999, 71, 2871-2882.
Gerner, C., Gotzmann, J., Frohwein, U., Schamberger, C. et al., Cell Death Differ. 2002, 9, 671-681.
Katayama, H., Nagasu, T., Oda, Y., Rapid Commun. Mass Spectrom. 2001, 15, 1416-1421.
Mire-Sluis, A. R., Wickremasinghe, R. G., Hoffbrand, A. V., Timms, A. M., Francis, G. E., Immunology 1987, 60, 7-12.
Gerner, C., Sauermann, G., J. Cell Biochem. 1999, 72, 470-482.
Hochstrasser, D. F., Harrington, M. G., Hochstrasser, A. C., Miller, M. J., Merril, C. R., Anal. Biochem. 1988, 173, 424-435.
Bradshaw, R. A., Burlingame, A. L., Celis, J. E., Mol. Cell. Proteomics 2003, 2, 1.
Griffin, T. J., Han, D. K., Gygi, S. P., Rist, B. et al., J. Am. Soc. Mass Spectrom. 2001, 12, 1238-1246.
1973; 52
1987; 60
2002; 9
2002; 7
2003; 2
2001; 19
2002; 1
2001; 409
2001; 15
2000; 275
2001; 1
1999; 72
1988; 173
1999; 71
2001; 12
Mire‐Sluis A. R. (e_1_2_1_16_2) 1987; 60
e_1_2_1_6_2
e_1_2_1_7_2
e_1_2_1_4_2
e_1_2_1_5_2
e_1_2_1_2_2
e_1_2_1_11_2
e_1_2_1_3_2
e_1_2_1_12_2
e_1_2_1_10_2
e_1_2_1_15_2
e_1_2_1_13_2
e_1_2_1_14_2
e_1_2_1_8_2
e_1_2_1_17_2
e_1_2_1_9_2
References_xml – volume: 1
  start-page: 528
  year: 2002
  end-page: 537
  publication-title: Mol. Cell. Proteomics
– volume: 1
  start-page: 699
  year: 2001
  end-page: 704
  publication-title: Proteomics
– volume: 19
  start-page: 242
  year: 2001
  end-page: 247
  publication-title: Nat. Biotechnol.
– volume: 72
  start-page: 470
  year: 1999
  end-page: 482
  publication-title: J. Cell Biochem.
– volume: 2
  start-page: 96
  year: 2003
  end-page: 106
  publication-title: Mol. Cell. Proteomics
– volume: 9
  start-page: 671
  year: 2002
  end-page: 681
  publication-title: Cell Death Differ.
– volume: 2
  start-page: 1
  year: 2003
  publication-title: Mol. Cell. Proteomics
– volume: 173
  start-page: 424
  year: 1988
  end-page: 435
  publication-title: Anal. Biochem.
– volume: 71
  start-page: 2871
  year: 1999
  end-page: 2882
  publication-title: Anal. Chem.
– volume: 52
  start-page: 2745
  year: 1973
  end-page: 2756
  publication-title: J. Clin. Invest.
– volume: 12
  start-page: 1238
  year: 2001
  end-page: 1246
  publication-title: J. Am. Soc. Mass Spectrom.
– volume: 409
  start-page: 860
  year: 2001
  end-page: 921
  publication-title: Nature
– volume: 275
  start-page: 39018
  year: 2000
  end-page: 39026
  publication-title: J. Biol. Chem.
– volume: 7
  start-page: 797
  year: 2002
  end-page: 801
  publication-title: Drug Discov. Today
– volume: 15
  start-page: 1416
  year: 2001
  end-page: 1421
  publication-title: Rapid Commun. Mass Spectrom.
– volume: 60
  start-page: 7
  year: 1987
  end-page: 12
  publication-title: Immunology
– ident: e_1_2_1_9_2
  doi: 10.1002/(SICI)1097-4644(19990315)72:4<470::AID-JCB3>3.0.CO;2-V
– ident: e_1_2_1_10_2
  doi: 10.1172/JCI107470
– ident: e_1_2_1_13_2
  doi: 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.0.CO;2-C
– ident: e_1_2_1_4_2
  doi: 10.1016/S1359-6446(02)02396-6
– ident: e_1_2_1_7_2
  doi: 10.1074/mcp.M200074-MCP200
– ident: e_1_2_1_12_2
  doi: 10.1016/0003-2697(88)90209-6
– volume: 60
  start-page: 7
  year: 1987
  ident: e_1_2_1_16_2
  publication-title: Immunology
  contributor:
    fullname: Mire‐Sluis A. R.
– ident: e_1_2_1_14_2
  doi: 10.1002/rcm.379
– ident: e_1_2_1_3_2
  doi: 10.1074/mcp.E300003-MCP200
– ident: e_1_2_1_6_2
  doi: 10.1016/S1044-0305(01)00316-6
– ident: e_1_2_1_11_2
  doi: 10.1074/jbc.M006495200
– ident: e_1_2_1_15_2
  doi: 10.1021/ac9810516
– ident: e_1_2_1_8_2
  doi: 10.1074/mcp.M200026-MCP200
– ident: e_1_2_1_17_2
  doi: 10.1038/sj.cdd.4401010
– ident: e_1_2_1_2_2
  doi: 10.1038/35057062
– ident: e_1_2_1_5_2
  doi: 10.1038/85686
SSID ssj0017897
Score 1.8799555
Snippet Comparative proteome profiling, performed by two‐dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually...
Comparative proteome profiling, performed by two-dimensional polyacrylamide gel electrophoresis or multidimensional protein identification technology, usually...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1314
SubjectTerms Autoradiography
Cells, Cultured
Databases, Factual - standards
Electrophoresis, Gel, Two-Dimensional
Endothelial cells
Endothelium, Vascular - chemistry
Endothelium, Vascular - drug effects
Fluorescence
Fluorescence detection
Humans
Jurkat Cells
Kinetics
Leukaemia
Lymphocyte Activation
Peptide Fragments - analysis
Phytohemagglutinins - pharmacology
Proteins - chemistry
Proteins - metabolism
Proteome - analysis
Proteome - chemistry
Proteome - metabolism
Sensitivity and Specificity
Subcellular Fractions
Sulfur Radioisotopes - metabolism
T-Lymphocytes - chemistry
T-Lymphocytes - drug effects
Trypsin
Two-dimensional gel electrophoresis
Umbilical Veins - cytology
Vascular Endothelial Growth Factor A - drug effects
Title Towards a standardized human proteome database: Quantitative proteome profiling of living cells
URI https://api.istex.fr/ark:/67375/WNG-6N7R2GJF-3/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpmic.200300774
https://www.ncbi.nlm.nih.gov/pubmed/15188398
https://search.proquest.com/docview/17974248
https://search.proquest.com/docview/72010342
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4heqA9QLu0ZekDHyp6CsSPJHZviHZBSF21CFRull-RVnSziN2VgF9fP0iWrVpVKscodmSPZzzjyedvAD44YbS3Gn_Iqa3NGLYs0zZXmRHKEuGw0THf8XVYHp-zk4vi4sEt_sQP0SXcgmXE_ToYuNLT_QVp6NV4FCkIaWCkCYSgmFYB0_f5tOOPwhVP1VW8286Ed0wta2NO9pe7L3mlJ0HAN38KOZcj2OiCBhug2sEn5Mnl3nym98zdb7yOj5ndc1i_j0_RQVKoF7Dimh5sHjT-bD6-RbsoIkZjKr4Ha4dttbgePHtAbLgJ8iyicadIoTZXMbpzFsWKgChyQ0zGDgV4anCjn9D3uWridTe_-S7ep4Li_otoUqOfo5D7QOFPw_QlnA--nB0eZ_elHDJT-ANZxgWzRjlseUEKLRjmTjHF_dnShyu5xcy4wlnNmKY5w7gUxDhLA41oyRUVir6C1WbSuC1AJa-1qPOaYh87Fczx2uS6qBQ3QmNe2j58bJdSXiXGDpm4mYkMUpWdVPuwG1e6a6auLwPOrSrkj-GRLIfVKTk6GUjah51WFaQXa5ioatxkPpV-O6sYYfzvLaoAN6CM9OF10qHFoAIXHhW-L4ma8I_Rym_eLrun7f_p9AaeJuBRwGu-hdXZ9dy98zHVTL-PdvMLfx4Zdg
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_B9jB4YNAxVjaYH9B4yhY7TmLzNm10ZWwVTJ3gzfJXpGprOq2tBPvr8ceSUgRCgscodmSf73zny8-_A3hjuVbOatwhpzImodjQRJlUJppLQ7jFWoV8x_mg6F_S0695gyb0d2EiP0SbcPOWEfZrb-A-IX2wYA29GY8CB2HmKWnoQ1h1No89quv4omWQwiWL9VWc4064c00Nb2NKDpb7L_mlVS_ib78LOpdj2OCEeuugmuFH7MnV_nym9vXdL8yO_zW_p_DkPkRFh1GnnsEDW3dg47B2x_Pxd7SHAmg0ZOM7sHbUFIzrwOOfuA03QAwDIHeKJGrSFaM7a1AoCogCPcRkbJFHqHpP-g59nss63Hhz--_ifawp7r6IJhW6Hvn0B_I_G6bP4bL3fnjUT-6rOSQ6d2eyhHFqtLTYsJzkilPMrKSSueOli1hSg6m2uTWKUpWlFOOCE21N5plECyYzLrNNWKkntd0CVLBK8SqtMuzCp5xaVulU5aVkmivMCtOFt81aiptI2iEiPTMRXqqilWoX9sJSt83k7ZWHupW5-DI4EcWgvCAnpz2RdWG30QXhxOonKms7mU-F29FKSij7c4vSIw4ySrrwIirRYlCeDi_jri8JqvCX0YpPzjTbp5f_0mkX1vrD8zNx9mHwcRseRRySh2_uwMrsdm5fuRBrpl4HI_oBIEQdlw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dTxQxEJ8oJH48oB6IJyh9MPi0sP3Y3ZY3Ah6IekECkbemX5tc4PYu3F2i_PW2XXaPMxoTfdxsu2mnM53p7K-_AXjnhNHeavwhp7Q2YdiyRNtUJUYoS4TDRsd8x5d-fnzBTi6zy3u3-Gt-iDbhFiwj7tfBwMe23J2Tho6Hg0hBSAMjDXsIyywnIrDnH561BFK44HV5Fe-3E-E9U0PbmJLdxf4Lbmk5SPj772LOxRA2-qDeM1DN6GvoydXObKp3zO0vxI7_M73nsHIXoKL9WqNewANXdWB1v_KH8-EPtI0iZDTm4jvw-KApF9eBp_eYDVdBnkc47gQp1CQrBrfOolgSEEVyiNHQoYBPDX50D32dqSred_O77_x9XVHcfxGNSnQ9CMkPFH41TNbgovfh_OA4uavlkJjMn8gSLpg1ymHLM5JpwTB3iinuD5c-XkktZsZlzmrGNE0ZxrkgxlkaeERzrqhQ9CUsVaPKvQKU81KLMi0p9sFTxhwvTaqzQnEjNOa57cL7ZinluKbskDU5M5FBqrKVahe240q3zdTNVQC6FZn81j-Seb84I0cnPUm7sNWogvRiDRNVlRvNJtLvZwUjjP-5RRHwBpSRLqzXOjQfVCDDo8L3JVET_jJaeeoNs316_S-dtuDR6WFPfv7Y_7QBT2oQUsBubsLS9Gbm3vj4aqrfRhP6CasiHEY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Towards+a+standardized+human+proteome+database%3A+quantitative+proteome+profiling+of+living+cells&rft.jtitle=Proteomics+%28Weinheim%29&rft.au=Traxler%2C+Elisabeth&rft.au=Bayer%2C+Editha&rft.au=St%C3%B6ckl%2C+Johannes&rft.au=Mohr%2C+Thomas&rft.date=2004-05-01&rft.issn=1615-9853&rft.volume=4&rft.issue=5&rft.spage=1314&rft_id=info:doi/10.1002%2Fpmic.200300774&rft_id=info%3Apmid%2F15188398&rft.externalDocID=15188398
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1615-9853&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1615-9853&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1615-9853&client=summon